Efficacy of salmeterol in the treatment of childhood asthma

Acta Paediatrica Japonica; Overseas Edition
N TomaçG Adalioğlu

Abstract

The aim of the clinical study reported here was to investigate the efficacy of salmeterol, a new long-acting selective beta 2-agonist, in patients with bronchial asthma. Twenty-four children with moderate asthma were enrolled in the longitudinal study, consisting of a run-in period of 2 weeks followed by a treatment period of 4 weeks. Maintenance treatment consisted of inhaled corticosteroid and disodium cromoglycate, or both, at the same daily dose throughout the study. During the run-in period, the patients continued to inhale salbutamol when needed and some of them (37%) also received theophylline. They were subsequently treated with salmeterol 50 micrograms twice daily and prn salbutamol for 4 weeks. Efficacy was evaluated using symptom scores and pulmonary function tests including forced vital capacity parameters, pulmonary volumes, airway resistance and specific airway conductance that were measured sensitively by a whole body plethysmograph. As a result, salmeterol produced significant improvement in morning and evening peak expiratory flow rates, vital capacity, airway resistance, conductance and asthma symptoms versus salbutamol and theophylline. Adverse reactions were judged to be mild and few.

References

Aug 20, 1977·Lancet·S T HolgateA E Tattersfield
May 1, 1977·The Journal of Allergy and Clinical Immunology·J W JenneF J Wall
Aug 1, 1992·Archives of Disease in Childhood·C P Green, J F Price
Oct 22, 1992·The New England Journal of Medicine·B J O'ConnorP J Barnes
Nov 12, 1992·The New England Journal of Medicine·D S PearlmanS W Yancey
Apr 1, 1992·The Journal of Allergy and Clinical Immunology·E Y DeromM E Van der Straeten
Jan 1, 1990·Lung·M Johnson
Dec 1, 1990·Lancet·O P TwentymanS T Holgate
Feb 1, 1991·The American Review of Respiratory Disease·R J MartinS J Szefler
Jul 1, 1985·The Journal of Allergy and Clinical Immunology·C SpringerS Godfrey
Oct 1, 1994·International Archives of Allergy and Immunology·L RamageD P Dhillon

❮ Previous
Next ❯

Citations

Oct 19, 2006·Pulmonary Pharmacology & Therapeutics·Iwona StelmachPiotr Kuna
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Bhupendrasinh F ChauhanFrancine M Ducharme
Jul 23, 2008·The Cochrane Database of Systematic Reviews·Christopher J Cates, Matthew J Cates
Jul 20, 2007·The Cochrane Database of Systematic Reviews·A K H TeeL B Irving
Mar 8, 2005·British Journal of Nursing : BJN·Sadie Clayton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.